You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Fine Water Mist Fire Suppression for Oxidizer Fires

    SBC: ADA TECHNOLOGIES, INC.            Topic: MDA04T004

    Fine water mist has been shown to be an effective fire suppression option in a number of applications, including oxidizer fires, such as could result from an incident with hydrogen peroxide. ADA Technologies, Inc. and the Colorado School of Mines will collaborate in the development of a novel system for this application, building and demonstrating a fine water mist system that uses a patented atom ...

    STTR Phase I 2004 Department of DefenseMissile Defense Agency
  2. STTR Phase II: Novel Nanocoated Ferromagnetic Materials

    SBC: ALD NANOSOLUTIONS, INC            Topic: N/A

    This Small Business Technology Transfer Phase II project will build on the great successes of the Phase I program by proving that the nanocoating of fine ferromagnetic particles is possible on the large scale and that such nanocomposite particles have commercial uses. The Phase I program proved that atomic layer deposition (ALD) of an alumina film can provide these properties.The objectives of the ...

    STTR Phase II 2004 National Science Foundation
  3. STTR Phase I: Benign Thin Film Composite Particles for Protection from UVA/UVB- Rays

    SBC: ALD NANOSOLUTIONS, INC            Topic: AM

    This Small Business Technology Transfer (STTR) Phase I project will develop composite TiO2/ZnO (Titania /Zinc Oxide) particles capped with an Al2O3 nanolayer for benign protection from UVA/UVB - rays. Titania (TiO2) provides excellent protection against UVB - rays. Zinc oxide (ZnO) protects against UVA-rays very efficiently. The manufacture of composite particles via novel Atomic Layer Deposition ...

    STTR Phase I 2004 National Science Foundation
  4. STTR Phase I: UV-Photocatalytic TiO2 Films on Nanosized Ferromagnetic Substrate Particles

    SBC: ALD NANOSOLUTIONS, INC            Topic: N/A

    This Small Business Technology Transfer (STTR) Phase I project provides for the commercialization of composite UV-photocatalytic TiO2 nanofilms deposited by Atomic Layer Deposition (ALD) on nanosized ferromagnetic iron particles. The iron nanoparticles are formed in-situ prior to ALD processing where conformal, pinhole-free, chemically bonded films of TiO2 are deposited on the surface of each indi ...

    STTR Phase I 2004 National Science Foundation
  5. Novel Polymer Nanocomposite Processing

    SBC: ALD NANOSOLUTIONS, INC            Topic: 20

    72212-The uniform dispersion of nanoceramic filler particles within a polymer matrix, for producing high quality polymer/ceramic nanocomposites, is a very time-and energy-intensive process. The development of efficient methods for uniformly dispersing nanoceramic inclusions, which are well-adhered to the polymer throughout the polymer matrix, and for fabricating parts from such composites at low ...

    STTR Phase II 2004 Department of Energy
  6. STTR Phase I: High Pressure Disaggregation of IVIg Formulations For Increased Yield and Safety

    SBC: BaroFold, Inc.            Topic: N/A

    This Small Business Technology Transfer Research (STTR) Phase I project proposes to use high pressures for disaggregation and proper refolding of aggregated proteins in commercial IVIg (immunoglobins for intravenous administration) formulations.The commercial application of this project will be in improved quality of therapeutic proteins for intravenous administration. Increased process yields wi ...

    STTR Phase I 2004 National Science Foundation
  7. Antiatherogenic Properties of tert-Butylhydroquinone

    SBC: BIOINVENTIONS, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Atherosclerosis is the underlying cause of most cardiovascular disease and considerable evidence supports the role of hypercholesterolemia as a risk factor for this disease. In preliminary work, we found that tertiary-butyl hydroquinone (TBHQ), at a dose lower than approved for human use, was effective in reducing plasma levels of both total cholesterol and tri ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  8. Real-Time Range Sensing Video Camera for Human/Robot Interfacing

    SBC: BOULDER NONLINEAR SYSTEMS, INC.            Topic: T502

    In comparison to stereovision, it is well known that structured-light illumination has distinct advantages including the use of only one camera, being significantly less sensitive to background clutter, and not requiring the target object to have nonambiguous features. But because structured-light illumination requires a scanning process, it is inappropriate for humancomputer interfacing where the ...

    STTR Phase I 2004 National Aeronautics and Space Administration
  9. Automated Detection of Steganographic Content

    SBC: COLORADO ENGINEERING INC.            Topic: AF04T008

    Colorado Engineering, Inc., a small woman owned business, and the University of Colorado at Colorado Springs are teaming to develop a Stegi@work architecture for an extensible, distributed application that can be utilized to detect steganographic content in media files, alert the user, and either mitigate (destroy) the content if possible or quarantine the files as appropriate. The key distinguis ...

    STTR Phase I 2004 Department of DefenseAir Force
  10. TGF-beta for Pleurodesis

    SBC: CUMBERLAND PHARMACEUTICALS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Approximately 50,000 cancer patients a year have recurrent fluid accumulation in the space between their chest wall and lung. This condition is called malignant pleural effusion (MPE). This fluid impairs breathing and worsens the quality of life in these patients. The current treatments are not ideal and include removing the fluid by repetitive needle aspiratio ...

    STTR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government